Brivo Going Public At $800 Million Valuation

By John Honovich, Published Nov 10, 2021, 09:21am EST (Research)

***** ** ***** ******, *** * ****, ****** ** more **** ****** *** ********** ****** next **** *** *** ***** ** come.

IPVM Image

*** ***** ********* ******** *** ****** rate? **** ** ***** *** ********* near **** ******* ******* ** ******* in **** * *****?

************* ** *****'* *******, *** ****'* test.

****** **** ****, ** ******* *** Investor's **** *** *** ********'* **** plus *** *******'* ***** *** ************ and **** ******* **** *****'* ***** company ***** *** ********.

Investor ****

*** ***** ******** ****** *** **** ******** ** *** with ********* ******* ** *** ***** and ** *** ***** ** *** reporting *** ******** ******.

IPVM Image

*** ********'* **** *** **** ** minutes, **** **** **** *** ***** release / **** *** *** *** take *** *********.

Summary: ****** ***** ****** ** **********

***** ** ******** ** ********* ******** its ******* ****** **** **** * historical ** - **% ** **%+ starting ** **** ** **** **** while ****** **** ****** ***** ***** so. *** ******* ** ********* "** to $*** ******* ** **** ********" to ** **.

******* ** ** * ***** ******** in *** ******** ** ***** ******** security *** ** ****** ********** ** meet **** ** ********* ****. *******, what ************ *** ******* ***** ***** materially ****** *** ******* ** *** company.

**** ** **** ** *** **** their ****, *** ******** ** ******** of ******** ** ******* **** ******* them * ****** ********* **** ***** conventional ****** ******* ***********.

Actual ********* ***********

**** *** **** *** *****, *****'* financial *********** *** **** *****, ******* total ******* **.*% ** **** *** 12.1% ** ****.

IPVM Image

****:***** **** ~$*.* ******* ** *** funding ** ********** *** ****** ** "*** *********" on ********** *********.

Projected ********* ***********

******* *** *** *******, ***** ******* its **** ******* ****** ** ** nearly **% *** ******** **** **** for ******* ** ******** *** **** rapidly:

IPVM Image

** *** **** ******** ***** ***** shows, ******** **** ****, ***** ******** 3+ ***** ** **% ****** *** even ** ****, **** **** ****** to ***** $***+ ******* *******, **** 40% ****** ****:

IPVM Image

Small *** ****** *********

***** ***** ** ********** **** **** high ******* ****** ****, **** *** also ********* * **** *** *** loss, **** $** ******* ***** **** the **** * ***** *** ******** by ****** $*** ******* ** ******* for **** *** ****:

IPVM Image

**** ******* ****** *** *** ****** tend ** ** ********* ** *******, especially ** *****'* *********** **** ****** more ********** ** ********* *** ***** access ******* ********.

Fit *** ***** ********** ********

*****'* *** ***** *** **** ******** on *** **** **** ***** ** a "*** *** ***** **** ** commercial ******** ** *** *****". ***** arguably ******* ** * *** *** every ****, *** ********** ********* ******** is *** **** ** *** ****** will ***** ****** * *** ***. Historically, *** ******* *** **** ******** competitively ** *****-**** ********** **** ********** smaller **** ******. *** ***** **** to **** ********** ********** **** *****, S2, *******, *********, ******** *****, ***.? Related, *********** ****** ******* ************* ******* ********** ********** ** ***** ****** its ******.

TAM *****

***** ******* **** ***** ****** *** is $**+ *******:

***** *** ******* ****- *** ***** device-based ***** *********** ****** (***) *** products *** ******** ********* ** ****** of $** *******

*********, ** *** ****** "***** ******-*****" devices *** ****** ** **** *** (e.g., **** ***** ******* ***** ************, intrusion, */*, ****, ***.

*******, ** ********* ***, *** ****** than **** **** ********* **** ***** - *** "***** ******" ******.

5x ** * *****

**** **********, ***** *********:

** ****** ***** ****** **** **** 5x ** * ***** *** ** end **** ****** *** ******** ********* that **** **** ********** ************

**** ***** *** ** * **.**% CAGR. ****** *** $** ******* ***, this ** ****** *** ***** ** possibility *** ***** ****** *******, ********* on **** *** ****** ** ***** cloud ** ************ ****** *******.

***** **** ******* **** ***** ** currently **-**% ** *** ****** ******* market ******* ****** *** ****** ****. That ** *********, ****** *** "****** rate" *** ****** ******* ** **** likely ** *** * - **% range - ******* ****** *** ******.

Acquisition ****

*** **** ****** *** *** *** of *** ********, **** ****** ** for "******* *********", *** ****** **** is *** ***** **** ********* *** the ******** ** ***** ******** *** expansion:

IPVM Image

*** **** ******* ********* ***** ***** for ************, ********** $** ******* ********* revenue ********* **** *****:

IPVM Image

*******, *** **** ******** ** **** frame ** ** ** ******* ** Brivo ***** ** ******* * ********* next **** ** ******** ****** ****. However, ***** ******** ****** *** ****** a *** ******* ******* ** **** certainly ***** ********** ********** ********* ******.

Zero *** ******* ******

*** *********** ***** ***** ***** ** that **** **** * "**** *** payback ******" *****, ** ***** ****** sounds *********, *** **** ******* ** by ****** **** *** ***** ******* they **** **** ******* ******** ** front ** ****** **** **** **** spend ** ***** *** ********* ** acquires *********, ** *** **** ******* below **********:

IPVM Image

Average ******** *** *********

******* *********** ******* ** **** **** project **** **** ******** ***** *** very *** ********* ****:

********** *** *** ** *** ******* over * ** **** ******* ******* life ******** *% ****** *********

***** ******* ****** ** ** ********* as ********** ****** ******* ********* **** to ****** **** ************ ******* ** terms **** *** *** ****** **** conventional ****.

IPVM Image

Drako ******* ******** *** *********** ***********

*****, *** ******** ***** ** **** for $** *******, **** ****** ******** *** *********** shareholder, **** *** ******* ******:

******** ***** ************ **** ** ******* 100% ** ***** ******. ***** ************ expected ** *** **% ** ****’* common ***** ****-***********

Eagle *** ******

*** ********* ** *** ******** *** future ** ***** *** ********, ******* Dean ***** ********** *******, ******* ** mentioning "* ********* ********** ** *** PIPE **** ***** *** ********." ****, Eagle *** ** ********* ** ***** going ******, ****** ****** * **** small *******.

** ** ********* ******** **** *** companies ***** ** ******** ** *** future, ********** *** **** **** **** a ********-****** ******* ** ** **.

[******] ***** *** *********:

***** *** ** ***** ** ******* with ***** ** **** ****. ***** generally *** **** * **** **** investor, *******, *** ****** *** *** of *** *********.

***********

***** ***** ****** ***********, ***** ** a ********* ******* ** ******* ** other ******** ****** *********. ***** ** an ******* ** *** ***********:

IPVM Image

***** ** * **+-****-*** ******* ***** its ******* ******** ****** ****** ******* peers *** *** ******* *** ******** from * *** ***** ******* **** and ****** *********** ** **********, ** it ** **** ** ********.

Outlook *****

*******, * ******** ********** **** ***** is ******* *** *** *******, ** it *** *** *********** ********* ** grow *** ***** **** *** ****** acquisitions ** * ******, **** ***** 20+ ***** ** ***** ****** *** finally **** **********.

*** ********* **** ** ******* ***** ambitious ****** ***** ***, ** **** do ***, ******* **** *** ******* of ****** *********.

Vote / ****

Comments (28)

*** *** ****?

******** ******.

Agree
Disagree: 1
Informative
Unhelpful
Funny

***** ** ***** ** ******** ******* 70% **** **** ** ****. ****'* ambitious ** *** *** *****.

Agree: 4
Disagree
Informative
Unhelpful
Funny

***** ** ***** ** ******** ******* 70% **** **** ** ****

**, ***** **** ** ******** ******* 579% **** **** ** **** (*.*., $72 ******* ** **** -> $*** million ** ****).

Agree
Disagree
Informative: 2
Unhelpful
Funny

**** **** * ***** ********* **** infusion, ** ***** *** ***** **** their *********** ** ******** ***** ******** near ****, ***** ********** ** **** their ********* ******* ******, ***** **** term ************* **** ******* *** ****.

******* ** ******* ********** ***** *** access ******* ******* ** *********, **** tend ** *** ****** ********. ********* is **** ****, *** **** **** throttle **** ****** ********, *** ******* soar.

**** **** ** **** *** *** original ***** ** **** *********. **** competitors ** ** ******** **** ********* if **** *** ***** ******* **** a ***** ****** ** *******.

** **** ** ********* ** ***** capital **** ** ************ **** ******** the ******** ********* ****. **** ** will ** * **** ***** *** new ********* ** ****. ******* ****** the **** **** *********** **** ** important *** ***** *** ******.

***** **** ********* ** **** *********, the ********* ****** ** **** **** Brivo *** ***** *** **** **** in ******.

******** **** *** *** ** ***** the ******* ********* ****** **** ** the ******* ** *** ********, *** this ***** ******* **** *** *********** by * **** ****** ******.

Agree
Disagree
Informative
Unhelpful
Funny

***** ***** **** ** * *******... the **** "********" ** *** **** Drako **** **** *** ****** *** keep *** **********.

Agree: 5
Disagree
Informative
Unhelpful
Funny

**********! ** ** ** ******** *** it **** *** **** ******* *** exit, *** ** ******* ***. *** industry *** ***** **** **** **** benefits ** ****.

***** ** * **** ****** ******* than ***** *** *** *** *** greater ****** *********. **** ********* **** been ***** *********** *** ********** **** other ******** *** ******** *********, ** well ** **** *****. *** ******* for ************ ** **** ***** *** Access ******* **** **** *******. *********** across *** ******* *** *** ****** generating ********** *** ********** ******* **** they **** **** ****. ***** ** certainly ** ********* *** ****, ** makes *** ***** **** **** **** term ******** ***** ** *** ******* created ** **** ** ******** ********* revenue ******.

** *** **** **** ****** **** enough, ** *** ****** ***** **** the ********* ** ****** *** ********* by ****** ******* *** ***** ******** is *** ******* **** ************ ******** and **** *******. ** ******** **** expertise *** **** **** ** *******. Access *** ***** ****** ********* ******** have ************ ************ **** *********. ********* driven ** ******* ******* ****** ****** for *** ********** *** ********** ** systems. *******/*** ***** **********, ******* ***** or ****** ** * ****** ********** tool *** **** ** ****** *** end ***** ** ** ****.

* ** *** * *** **, nor ** * ******* ***** ***** Security ********* *** * **** ****. They ******* ******* * ****** ***** of ***** ****** *** *******, *** security ***** ***** ***** ********* ** not. **********, **** **** ********* ****** for, *** ****** **** *** ******** a ********* ******* ****** ** *** Access *** ***** ****** *******. ** has ****** ****** *** ***** ** only **** ****** ****** *** ******. With **** ** ***** ** **** industry, ** **** ***** **** ****** for ***** ******** ******.

***** *** **** ** **** ****** for * *****. ** ** ** investor, *** *** ****** ********* ** this ******** *** *** *** * wonderful ******. ** **** *****, ** can ** **** ****. ** *** help ****** **** *** ****** *** Video ******* *******, *** ******* ** pay ********* ******* **** ** **** of *** *******. **** **** ******* his *********** *** *** ** ** in *** ******** *** **** ****** industry.

*** *********** ***** ***** **** ***** is **** ** ******* ****** *********, marketing ****** ******* ********* *** ****. Cash **** ********, ******** *********** ***** goes ****, *** ********* ************* ***** off. **** ******** ***** **** *** potential ** ******* **** **** *** investments *** ********* ********* ******** *** other ******** ***** ******* *********.

********* ****** *** ******** ****** ******* to *** ********, *** ******** *** everyone ******* ** **.

*** *** *****, ******* ***** **** collect *** ***, *** ***** ****** to ***** ****** *** ************ ** the ******** ** *** **** ***, instead ** ***** ********** ** *** of **** ********* ********.

** ****** * ***** **** * stocking ** *** ********* *** ***** cookies *** *** *****.

Agree
Disagree
Informative: 1
Unhelpful
Funny: 3

**** ** * ****** *** *** long ***** **** *** *** *********, but * ***** *******.

Agree: 1
Disagree
Informative
Unhelpful
Funny: 2

*** *** *****, ******* ***** **** collect *** ***, *** ***** ****** to ***** ****** *** ************ ** the ******** ** *** **** ***, instead ** ***** ********** ** *** of **** ********* ********.

********** **** *** ** ********.

Agree
Disagree
Informative
Unhelpful
Funny

***** ** * **** ****** ******* than ***** *** *** *** *** greater ****** *********.

****'* ** *********** **********. ***** * better ******* **** ***** *** ** not ****** ****** ******, ****** (******** *** ***** *** *** ****** Test ****).

*** * ** *** **** ***** the ****** *********. *** ***** ************ market ** ** ** ** ** big ** *** ****** ******* ******. I ******'* ** ********* ** ***** Eye's **** ******* ** ****** ***** to *****'*, ******* ***** ***** ** years *****.

* ** ****** ** *** ****** potential ** ********* *** *** ** more **** ******* **** **********. ****** is **** ***** ** ********** *** value ** ********* *******, *** * am *** *******.

Agree
Disagree
Informative
Unhelpful
Funny

*'* ** ******, *** *** **** of ********* ****** **********.... *** ***** have *** ****** ** ****-**** ** me. **** *** ******* '*****', *** nobody ****** ***** ********* *** ***** work, *** *** ************* ** *** industries **** *** ********* ** **** in.

** ** ********** ****** *******, **** you ***** * '*******' ** ** 'formed' ***** ******** ** **** ****** a *** **** ** ***** **** no ****** ******* ** *******, *** allow ***** **** *** **** ***** to ****** ***...

*** **** **** ***** ************* (***** the ***** ** ****** *** ****** in ***** '*******') **** *** ** make **** ***** ** ***** *** pile **** **** ****** - ** they *** ****.

* ***'* **** *****!

Agree
Disagree
Informative: 1
Unhelpful
Funny

*** *** ** **** ********* **** venture ******* ** ******* ****** *******, which **** ********* ** **** ******** have *********.

Agree
Disagree
Informative
Unhelpful
Funny

*****... *** ** ******.

*** ***'* ******* ******* *** ******* equity ******* **** ** ****** *** then ******* ********** '******' ** ********* who **** ***** ******* ******?

*** ******** ***********... ******** **** ******* followed ** * ****** ** ******* for **** *** ****. *** **** have * *****. ** **** **** Wars ******* ***** **** ********** *** many ****** ****, *** ************, ***** is **** ** **** **** ** these ****** ***** *** **** **** can **** ** ******** ** *******.

** ** **************** ****** ****, ** sure ***** **** ***** *** **** the ****** *** **** *** ****** of ***** *** ***** ** ***** use ** ** **** ****** ***** - *** **** *** ************ ** the ***, ******** **** ****** ********** regardless ** *** ****** **** ** their ****.

Agree
Disagree
Informative
Unhelpful
Funny

*** ***'* ******* ******* *** ******* equity ******* **** ** ****** *** then ******* ********** '******' ** ********* who **** ***** ******* ******?

********* ******* ******* ** **** *** the ***** *** ****** *****, *** PE ** *** ***** ** **** to **** *** ***** ********* **** has ****** ** * ***** **** you *** ********** *********** **** ****** growth.

*** ** ********* ** **** ** like ******* ********, ****** **** **** around ******* ** *** ***** **** get **, *** ***'* ****** **** what *** ******* ** ***** ** be. ** ***** ********** ***********. ***, through ******** ******, ** ******* **** the ********** ** *** ******** **** to ****** **** ******* **** **** would **** ** ** ** ***** investors, ** ***** ***** ** ********* commonly **** ** **** ****** * majority ****** ***** ** *****, ** at * ******* * ****** *********** voice ** *** ********* ** *** company.

*****, **, *** ** ****** *** raise ***** ***** **** ****** **** know ******* *** ** **** **** are ***** ** ****** **, ** they *** *** **** ******** ******* for ***** ********* ** * ***.

** ** **************** ****** ****, ** sure ***** **** ***** *** **** the ****** *** **** *** ****** of ***** *** ***** ** ***** use ** ** **** ****** *****

**'* *** ****** *** **** *** of * *******, **'* **** **** extremely ******* ********. *** ** *** the ***** (****, **, **) **'* all ***** ** ***** **** *** looking *** **** ** **** *** they're ******** **** ******* **** ********* in **** ******.

(*'* ******** ******* *'* **** *** above, *** ****'* **** ** **** that ******* ***********).

Agree
Disagree
Informative: 1
Unhelpful
Funny

****** *** - **** *******.

**'* *** ****** *** **** *** of * *******, **'* **** **** extremely ******* ********.

*** *** ******** ** **** ********** recently?

*'** ***** **** ***** **** **'* 'easier' **** * ****** ***... ***** sounds * *** **** '**** **********' to **** ****.

** ****'* ****, **** ***** *** 'avoiding **********' **** ** **** * smell.

Agree: 1
Disagree
Informative
Unhelpful
Funny

*** *** ******** ** **** ********** recently?

**** ** *******, ********* **** **** have ******** ** *** ********* *** fear. ** **** *****, *** * think **** ** **** *** *****, it **** *** ******* ** ** IPO ** ** *********** ********, **** the ******* ** ***** ** ** slow **** *** ******* ***** *** way ******* *** **** ********** *** get **** *** ** * *********** IPO *** *** ********** *******.

**** ***** *** '******** **********' **** is **** * *****.

********* ** **** ** ****, ** that ******* *** *** *****, ***'** still * ****** *******, ***** ***** up * *** ** **** *** facts ***** **** ******** ** ******* scrutiny **** **** *** ***** **** you *** ****** ** ******* ***** (VC, **, ****-******, ***.). ** *****, while ***** *** ******** **** ***** be ***** ***** *******, * ***** for ** *********** ******* **** *****, the ****** ** ** ******, ******* whatever *****, ** **** ** * sign ** ******** *** ********** **** not.

Agree
Disagree
Informative: 3
Unhelpful
Funny

*** ***** ***** **** *** **** money ** ****** ***...

*** ****'* *** ****** ** *****. And ***** *********, **** ** *** always *** ****, **** ***** ** often * ***** ****** ** *** wins ** ***** ** *******. **** of ***** ********* *** ***** ** magic ** ** *&*. ** **** is ***** ** *********** ********* *** ability ** ********/****** ***********.

Agree
Disagree
Informative
Unhelpful
Funny

*** ***** *********, **** ** *** always *** ****, **** ***** ** often * ***** ****** ** *** wins ** ***** ** *******.

****.

*** * **** ****** **** *** said ****** - ***** ****** ****.

*** * **** ****** *** ******* the **** ***** ****** **** ******* best ********* ** ******** ***** - but ******* ********* ******** ** ******** X *** ******* ****** **** ***** with *** *** ***** ** ***** and ***** **** - ** ***** big ***** ** ***** *** ******* to************** * ********* ** ******** *** size ** ***** ***** ** ***** on ****.

*** ******** ** ** *** ***** are *** ********** ** ** / PE... *** ** **** ******* ***** is **** * ***'* **** *****!

* **** ********* **** **** ***** is *** ** ********* ** **** close... * **** ** ******* ***** my **** ** *** ****.

Agree
Disagree
Informative
Unhelpful
Funny

*** *********** **** *********, *** ***** investor ***** ** *** *** ***** money ** ***** ******. ** ** an ******** ****** *****.

* ******* **** *** ******* ** most *********** *** **** *** ******. Traditionally, **** ******** *********** *** **** with *** **** ** ******* * ROI (****** ** **********)

********* ******* *** ***** *** ****** and ***** **** * ******* *** result ** **** ********** *** ******* and ******* *** *********.

******** * ******** ** **** ** a ****** ** * ********** ******* term ********** ******** *** ******** ** viable *** ******* . **** ** especially **** ** *** ******** ******** a ****** ******* ** *******, ******* employment *************, *** ******* *** *** new ******.

** ***** ***, *** ******** ** public ********* **** ******* ** ** long **** ********** ******** ********* ***** and ********* ** ***** ****** ** investors. ***** *** ******** *** ***** creating ****** *** *** ******* ******** and ***** *******, *** *** *********** assuring **** **** ********* ** *******. Too **** *** ********** *** *** created ** ****** ****** *********. ********* that **** ******.

Agree
Disagree
Informative
Unhelpful
Funny

******** ****** *** ********* ***** *****'* ability ** **** ***** $*** ******* 2025 ******:

IPVM Image

* ***** ** ********* ** **** did *** ***** $*** ******* ** revenue. * ***** **** ** ********* if **** **** ***** ** ***** $412 ******* ******* / $**.* ******* profit ****, ****** ********* ** **** acquisitions **** **, **** ***** ********* beat *** ***-**** ******.

Agree
Disagree
Informative
Unhelpful
Funny

********* *** ****** ******* *** **, the ******* ****** ******* ******* ** indication **** **** *** ******** ** have *********** *** ******. ** **** point ** **** *** *** **** burn ** *** **** ******** *** investors.

********* ** **********, ** ***** ** a **** ****.

** ****** *** ****** ** **** for *****.

Agree
Disagree
Informative
Unhelpful
Funny

*** ******* ****** ******* ******* ** indication **** **** *** ******** ** have *********** *** ******

**** **** ****** $*** *******, *****'* no ******** **** **** *** ****, the ******** ** *** ****.

Agree
Disagree
Informative
Unhelpful
Funny
Agree
Disagree
Informative
Unhelpful
Funny

[******] ***** *** *********:

***** *** ** ***** ** ******* with ***** ** **** ****. ***** generally *** **** * **** **** investor, *******, *** ****** *** *** of *** *********.

Agree
Disagree
Informative
Unhelpful
Funny

******, ***** ******** * ****** ** questions **** *****, ****** *****:

  • ***** *** *** *** ** $** billion **** ****?

    **'* * *********** ** ******* *** SaaS ******* *** *** *** ***** for ***************** ******** *********, ********* ****** *******, visitor **********, ***** *********, ***** ********, and ****** *********** *** *** ***** American, **, *** ***** *******. *** sources *** * *********** ** ******** analyst ******* *** ******** ********* ***********.
  • **** ** *****'* ***** *** *** shares ** *** ****** *******? ****** them ****-**** ** *********?

    ** *** ****** ** ******* ** his ******.
  • *** $** ******* ** ******* **** acquisitions - ** **** *** **** year? *** **** ***

    *** $*** ****** ** *** ******** Presentation ** *** *** ** *** approximate ****** ******** ** ***** ********* acquisition *************, ******* ******* ** ** when **** ************ ***** *****.
  • ********* ** ********* *** ***** *** bigger, ***** ****** **** *********** *******. However ***** *********** *** *** **** higher *****. *** ********* **** *** be *********, *** ******** ** ******** them?*** *********** ******* *** *********** ******* that ******* ******* ******, ******** ** the ****** ******** **** *** **** established, *** ******* ** ********** *** proven **** *** ****** ********, *** supported ** ********** *********.
Agree
Disagree
Informative
Unhelpful
Funny

*** ****** -******** *********** ********* ****:

IPVM Image

** * ******, **** **** ****** boilerplate *** * ** ****** ******* some ******** ******** *******.

Agree
Disagree
Informative
Unhelpful
Funny

******: ***** ********* ** ******* *** recently ********* **** ******* ** ** modestly ****** **** ** ********** ********** 2 ****** *** **** **** ************ was ****:

** ******* ** ********** *** ******* 2021 ******* *******. *** ******* ******* full **** **** ***** ******* ** be ******* $**.* ******* ** $**.* million, ** **** *** ***** *********** of $**.* *******.

**** **** ** ****** *********** ** how **** **** *** **** ******* projection ***** ****'* **** ******* ****** rate ** ~**% ***** ****'* ********* rate ** ******** ** ** **** than ****** **** ** **.*%.

Agree
Disagree
Informative: 1
Unhelpful
Funny

******,* ***** **** ****** ************ ***** *** ** ** ** the **** ****, ******** ** ** “every ****** **** ** ****,” ************ ** *** ******* ***-*** ****** this ****, ******* *** ******* ** 50% ** **. ******** ******* ~** new ********* ** ***** ** *** past ****:

IPVM Image

**** ****, ***** **** **** **** investors **** **** **** ******* **** than **% **** **** *** **% next ****, ** ***** ******* ***** for **** ** ** ****** ** that **** (** **** ****** ** they *** **** ****** ********* ******).

Agree
Disagree
Informative: 1
Unhelpful
Funny

*** ********* **** *****'* ************** ***** ** ***** *****, ***** not ****** ** **** *** ******* comparison ** *****:

** **** **** ** **** ** over **%, *** **** ****** ***** to ** ********** ** *** ******* that *** *** **** *** ** seven *****, *** ** *** ****** has **** ****-********. *** ** ** have **** ******* ***** ******* ** our **** ********. **** ***'* ******,we **** **** ******* ***** ******* ** *** ******** ******* ******** -- the electronic IoT devices that go into the buildings and connect the buildings to the cloud. And so that's allowed us to grow basically with our own gross margin fueling that growth. So when you look at last year with greater than 25% growth, we're not chewing up VC money, we're *** ******* ** ** *****. ****'* ******** ****** **** **'** ******, so to speak, and doing our growth that way. That's a big difference from most ** *** ***** that are going out there or have gone out there. The targets are usually burning * ***** **** ** ****. **** ** ***** ******* **** ***** **** **********, which we have. And so from a financial performance standpoint, I would say bigger gross margins than almost any other target you're likely to see out there, a history of profitability, and a history of growth without the consumption of outside capital, all pointing to the ability to grow much more rapidly with the influx of capital that we're expecting from the Crown PropTech merger. [emphasis added]

*** **** ********** ** *** **** and ****** ** ***** ***** ****:

** **'** *** *** ****** ** sales ***** ***, *** ****'* *** of *** ** ** ****** ** the ******* *******. ** **'* * bit **** * ***** ** *** company **********. ** ** ** ** those *** **** ** **** *****-******** field ***********. *** ********* *** ** customer *******, ******** *******, ****** **** that. ** **** **** ** ***** to **** ** **** **** ****** over *** **** ******* *****.

***, ******** **** ***** ****** ********* growth ** **% ** *** **** 6 ******:

IPVM Image

***** **** ********* ** ***** ****** its ******* ****** **** **** **** to ~**%.

Agree
Disagree
Informative: 2
Unhelpful
Funny
Subscribe to IPVM Research to read the full report.
Why do I need to subscribe?
The IPVM Research Service includes products tests and shootouts plus competitive and financial analysis, helping decision-makers better evaluate purchasing, partnering, developing, and/or competing against companies in physical security.
Already have an account?
Loading Related Reports